Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia

Pediatrics

Volumn 100, Issue 4, 1997, Pages 671-674

  Gussinyé, Miquel ^a   Carrascosa, Antonio ^a,b   Potau, Neus ^a   Enrubia, Manuel ^a   Vicens Calvet, Enric ^a   Ibáñez, Lourdes ^a   Yeste, Diego ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

Adult height; Bone mass peaking; Bone mineral density; Gonadal function; Salt wasting form of congenital adrenal hyperplasia; Skeletal mineralization

Indexed keywords

ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE MINERALIZATION; CHILD; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FRACTURE; HUMAN; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; SODIUM EXCRETION;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; BODY HEIGHT; BONE DENSITY; CALCIFICATION, PHYSIOLOGIC; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROCORTISONE; INFANT; MALE;

EID: 0030823277     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.100.4.671     Document Type: Article

References (38)

1. White PC, New MI, Dupont BO. Congenital adrenal hyperplasia. I. N Engl J Med. 1987;316:1519-1524
2. White PC, New MI, Dupont BO. Congenital adrenal hyperplasia. II. N Engl J Med. 1987;316:1580-1586
3. Cutler GB Jr, Laue L. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med. 1990;323:1806-1813
4. Dimartino-Nardi J, Stoner E, O'Connell A, New MI. The effect of treatment on final height in classical congenital adrenal hyperplasia (CAH). Acta Endocrinol. 1986;279:305-313
5. Young MC, Ribeiro J, Hughes IA. Growth and body proportions in congenital adrenal hyperplasia. Arch Dis Child. 1989;64:1554-1558
6. Klingensmith GJ, Garcia SC, Joner HW, Migeon CJ, Blizzard RM. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation and fertility. J Pediatr. 1977;90: 966-1004
7. Kirkland RT, Keenan BS, Holcombe JH, Kirkland JL, Clayton GW. The effect of therapy on mature height in congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1978;47:1320-1324
8. Urban MD, Lee PA, Migeon CJ. Adult height and fertility in men with congenital virilizing adrenal hyperplasia. N Engl J Med. 1978;299: 1392-1396
9. George W, Clayton MD. Patterns of growth from birth to maturity in infants and children with congenital adrenal hyperplasia. Acta Endocrinol. 1986;279:295-304
10. Gussinyé M, Potau N, Vicens-Calvet E, et al. Talla adulta, patrón de crecimiento y desarrollo puberal en pacientes con hiperplasia suprarrenal congénita forma perdedora de sal. Med Clin (Barc). 1997;108:87-90
11. Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD. Bone mineral density and body composition in congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1995;80:2238-2243
12. Mora S, Saggion F, Russo G, et al. Bone density in young patients with congenital adrenal hyperplasia. Bone. 1996;18:337-349
13. Johnston GC, Slemenda CHW, Melton LJ. Clinical use of bone densitometry. N Engl J Med. 1991;324:1105-1119
14. Lindsay R. Prevention and treatment of osteoporosis. Lancet. 1993;341: 801-805
15. Glastre C, Braillon P, David L, Cochat P, Meunier PJ, Delmas PD. Measurement of bone mineral content of the lumbar spine by dual-energy x-ray absorptiometry in healthy children: correlations with growth parameters. J Clin Endocrinol Metab. 1990;70:1330-1333
16. Southard RN, Morris JD, Mahan JD, et al. Bone mass in healthy children: measurement with quantitative DXA. Radiology. 1991;179: 735-738
17. Katzman DK, Bachrach LK, Carter DR, Marcus R. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab. 1991;73:1332-1339
18. Theintz G, Buchs B, Rizzoli R, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab. 1992;75:1060-1065
19. Del Rio L, Carrascosa A, Pons F, Gussinyé M, Yeste D, Domenech FM. Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: changes related to age, sex, and puberty. Pediatr Res. 1994;35:362-366
20. Del Rio L, Romera M, Pavia J, et al. Bone mineral density in two different socio-economic population groups. Bone Miner. 1992;18: 159-168
21. Carrascosa A, Silber THJ. Osteoporosis: a pediatric concern?. Int Pediatr. 1996;11:84-94
22. Bachrach LK. Bone mineralization in childhood and adolescence. Curr Opin Pediatr. 1993;5:467-473
23. Carrascosa A, Gussinyé M, Yeste D, Del Rio L, Audí L. Bone mass acquisition during infancy, childhood and adolescence. Acta Paediatr. 1995;411(suppl):18-23
24. Carrascosa A, Gussinyé M. Skeletal mineralization during puberty and adolescence: nutritional and hormonal regulation. Ann Nestlé. 1995;53: 92-100
25. Ibáñez L, Potau N, Zampolli M, et al. Source localization of androgen excess in adolescent girls. J Clin Endocrinol Metab. 1994;79:1778-1784
26. Hernández N, Sánchez E, Sobradillo B. Curvas y tablas de crecimiento. In: Argente J, Carrascosa A, Gracia R, Rodriguez-Hierro F, eds. Tratado de Endocrinologia Pediátrica y de la Adolescencia. Madrid, Spain: Edimsa; 1993:1119-1177
27. Raisz LG, Kream BE. Regulation of bone formation. I. N Engl J Med. 1983;309:29-35
28. Raisz LG, Kream BE. Regulation of bone formation. II. N Engl J Med. 1983;309:83-89
29. Raisz LG. Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med. 1988;319:818-828
30. Dempster DW, Lindsay R. Pathogenesis of osteoporosis. Lancet. 1993; 341:797-801
31. Slemenda CW. Body composition and skeletal density: mechanical loading or something more? J Clin Endocrinol Metab. 1995;80:1761-1763
32. Gutai JP, Meyer WJ III, Kowarski AA, Migeon CJ. Twenty-four hour integrated concentration of progesterone 17 hydroxyprogesterone and cortisol in healthy male subjects. J Clin Endocrinol Metab. 1979;44: 116-120
33. Zadik Z, de Lacerda I, Kamargo AH, Hamilton BP, Migeon CJ, Kowarski AA. A comparative study of urinary 17-hydroxycorticosteroids, urinary free cortisol, and the integrated concentration of plasma cortisol. J Clin Endocrinol Metab. 1990;52:1099-1101
34. Guenther HL, Fleisch H. Comparative study of deflazacort, a new synthetic corticosteroid, and dexamethasone on the synthesis of collagen in different rat bone cell populations and rabbit articular chondrocytes. Calcif Tissue Int. 1984;36:145-152
35. Meunier PJ, Dempster DW, Edouard C, Chapuy MC, Arlot M, Charhon S. Bone histomorphometry in corticosteroid-induced osteoporosis in Cushing's syndrome. Adv Exp Med Biol. 1984;171:191-200
36. Hyams JS, Carey DE. Corticosteroids and growth. J Pediatr. 1988;113: 249-254
37. Sambrook PHI, Birmingham J, Kelly P, et al. Prevention of corticosteroid osteoporosis. N Engl J Med. 1993;328:1747-1752
38. Zelissen PMJ, Ronald JM, Croughs RJM, van Rijk PP, Raymakers JA. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison's disease. Ann Intern Med. 1994;120:207-210